Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ego Seeman

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Frontiers in Endocrinology|September 22, 2018
Advances and Unmet Needs in the Therapeutics of Bone FragilitySabashini K Ramchand, Ego Seeman
Bone|March 31, 2004
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapyPierre D Delmas, Ego Seeman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2016
Abaloparatide Is an Anabolic, but Does It Spare Resorption?T John Martin, Ego Seeman
Neurospine|January 3, 2024
Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Related Protein PathwayThomas John Martin, Ego Seeman
Handbook of Experimental Pharmacology|April 2, 2020
Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic TherapySabashini K Ramchand, Ego Seeman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2015
Osteoporosis: Treat or Let Die Twice More LikelyTuan V Nguyen, Ego Seeman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 13, 2016
Challenges in the Use of Cross-Sectional Data to Quantify Growth and Deterioration of Bone Structure During Advancing AgeAli Ghasem-Zadeh, Ego Seeman
Best Practice & Research. Clinical Rheumatology|December 1, 2009
Quantifying the material and structural determinants of bone strengthMary L Bouxsein, Ego Seeman
Lancet (London, England)|September 19, 2006
Compliance with osteoporosis therapy is the weakest linkJuliet E Compston, Ego Seeman
Best Practice & Research. Clinical Endocrinology & Metabolism|November 26, 2008
Bone remodelling: its local regulation and the emergence of bone fragilityT John Martin, Ego Seeman
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Frontiers in Endocrinology|September 22, 2018
Advances and Unmet Needs in the Therapeutics of Bone FragilitySabashini K Ramchand, Ego Seeman
Bone|March 31, 2004
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapyPierre D Delmas, Ego Seeman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2016
Abaloparatide Is an Anabolic, but Does It Spare Resorption?T John Martin, Ego Seeman
Neurospine|January 3, 2024
Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Related Protein PathwayThomas John Martin, Ego Seeman
Handbook of Experimental Pharmacology|April 2, 2020
Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic TherapySabashini K Ramchand, Ego Seeman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2015
Osteoporosis: Treat or Let Die Twice More LikelyTuan V Nguyen, Ego Seeman
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 13, 2016
Challenges in the Use of Cross-Sectional Data to Quantify Growth and Deterioration of Bone Structure During Advancing AgeAli Ghasem-Zadeh, Ego Seeman
Best Practice & Research. Clinical Rheumatology|December 1, 2009
Quantifying the material and structural determinants of bone strengthMary L Bouxsein, Ego Seeman
Lancet (London, England)|September 19, 2006
Compliance with osteoporosis therapy is the weakest linkJuliet E Compston, Ego Seeman
Best Practice & Research. Clinical Endocrinology & Metabolism|November 26, 2008
Bone remodelling: its local regulation and the emergence of bone fragilityT John Martin, Ego Seeman
Pageof 17